These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2453120)

  • 1. Ultrastructural characteristics of new vessels in proliferative diabetic retinopathy.
    Williams JM; de Juan E; Machemer R
    Am J Ophthalmol; 1988 May; 105(5):491-9. PubMed ID: 2453120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial fenestrae in proliferative diabetic retinopathy.
    Wallow IH; Geldner PS
    Invest Ophthalmol Vis Sci; 1980 Oct; 19(10):1176-83. PubMed ID: 6158494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pars plana vitrectomy in proliferative diabetic retinopathy].
    Krampitz-Glaas G; Laqua H
    Klin Monbl Augenheilkd; 1986 Apr; 188(4):283-7. PubMed ID: 2425120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of proliferative diabetic retinopathy.
    Gündüz K; Bakri SJ
    Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neovascularization from scleral wound as cause of vitreous rebleeding after vitrectomy for proliferative diabetic retinopathy.
    Sawa H; Ikeda T; Matsumoto Y; Niiya A; Kinoshita S
    Jpn J Ophthalmol; 2000; 44(2):154-60. PubMed ID: 10715383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of placenta growth factor in proliferative diabetic retinopathy.
    Khaliq A; Foreman D; Ahmed A; Weich H; Gregor Z; McLeod D; Boulton M
    Lab Invest; 1998 Jan; 78(1):109-16. PubMed ID: 9461127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescein angiography of peripheral retina and pars plana during vitrectomy for proliferative diabetic retinopathy.
    Terasaki H; Miyake Y; Awaya S
    Am J Ophthalmol; 1997 Mar; 123(3):370-6. PubMed ID: 9063247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The specificity of the ultrastructural pattern of neoplastic vessels of the retina in diabetic retinopathy].
    Sdobnikova SV; Chekmareva IA; Fedorov AA; Mazurina NK; Kochetkova EA
    Vestn Oftalmol; 2005; 121(1):25-9. PubMed ID: 15759844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent proliferations in macular pucker, diabetic retinopathy, and retrolental fibroplasialike disease after vitrectomy.
    de Juan E; Lambert HM; Machemer R
    Graefes Arch Clin Exp Ophthalmol; 1985; 223(4):174-83. PubMed ID: 2414158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Temporary silicone oil implantation following vitrectomy in proliferative diabetic retinopathy].
    Gnad H; Skorpik C; Paroussis P; Menapace R; Radda TM; Prskavec FH; Grasl M
    Klin Monbl Augenheilkd; 1986 Nov; 189(5):388-90. PubMed ID: 2433498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endodiathermy plus photocoagulation as treatment of sclerotomy site vascularization secondary to pars plana vitrectomy for proliferative diabetic retinopathy.
    Nadal J; Carreras E; Canut MI
    Retina; 2012 Jul; 32(7):1310-5. PubMed ID: 22466471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrovascular ingrowth and recurrent haemorrhage following diabetic vitrectomy.
    West JF; Gregor ZJ
    Br J Ophthalmol; 2000 Aug; 84(8):822-5. PubMed ID: 10906084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vitrectomy and subsequent photocoagulation in proliferative diabetic retinopathy with vitreous hemorrhage].
    Gerke E; Alvira G
    Klin Monbl Augenheilkd; 1986 Jan; 188(1):5-8. PubMed ID: 2421045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of glial involvement in proliferative diabetic retinopathy.
    Ohira A; de Juan E
    Ophthalmologica; 1990; 201(4):187-95. PubMed ID: 2077455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neovascularization from the scleral wound as the cause of vitreous rebleeding after vitrectomy for proliferative diabetic retinopathy].
    Sawa H; Ikeda T; Matsumoto Y; Niiya A; Kinoshita S
    Nippon Ganka Gakkai Zasshi; 1998 Mar; 102(3):200-6. PubMed ID: 9558843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [One year outcomes of pars plana vitrectomy in proliferative diabetic retinopathy].
    Tadera M; Kawamura H; Fujikawa M; Kakinoki M; Sawada T; Saishin Y; Ohji M
    Nippon Ganka Gakkai Zasshi; 2014 Jun; 118(6):502-7. PubMed ID: 25016792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pars plana lensectomy, pars plana vitrectomy, and silicone oil tamponade as initial management of cataract and combined traction/rhegmatogenous retinal detachment involving the macula associated with severe proliferative diabetic retinopathy.
    Douglas MJ; Scott IU; Flynn HW
    Ophthalmic Surg Lasers Imaging; 2003; 34(4):270-8. PubMed ID: 12875454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vitrectomy and proliferative diabetic retinopathy. Apropos of 66 eyes].
    Bouchard O; Zech JC; Trepsat C
    J Fr Ophtalmol; 1997; 20(4):263-70. PubMed ID: 9181137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitrectomy for proliferative diabetic retinopathy with severe equatorial fibrovascular proliferation.
    Han DP; Pulido JS; Mieler WF; Johnson MW
    Am J Ophthalmol; 1995 May; 119(5):563-70. PubMed ID: 7733181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute onset of rubeosis iridis after diabetic vitrectomy can indicate peripheral traction retinal detachment.
    Bopp S; Lucke K; Laqua H
    Ger J Ophthalmol; 1992; 1(6):375-81. PubMed ID: 1283355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.